Citrix 2012 Annual Report Download - page 43

Download and view the complete annual report

Please find page 43 of the 2012 Citrix annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 118

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118

39
Valuation and Classification of Investments
The authoritative guidance defines fair value as the price that would be received to sell an asset or paid to transfer a
liability in an orderly transaction between market participants at the measurement date (an exit price). Our available-for-sale
investments are measured to fair value on a recurring basis and accordingly are carried at fair value. In addition, we hold
investments that are accounted for based on the cost method. These investments are periodically reviewed for impairment and
when indicators of impairment exist, are measured to fair value as appropriate on a non-recurring basis. In determining the fair
value of our investments we are sometimes required to use various alternative valuation techniques. The authoritative guidance
establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the
use of unobservable inputs by requiring that the most observable inputs be used when available.
The authoritative guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair
value as follows: Level 1, observable inputs such as quoted prices in active markets for identical assets or liabilities, Level 2,
inputs, other than quoted prices in active markets, that are observable either directly or indirectly, and Level 3, unobservable
inputs in which there is little or no market data, which requires us to develop our own assumptions. Observable inputs are those
that market participants would use in pricing the asset or liability that are based on market data obtained from independent
sources, such as market quoted prices. When Level 1 observable inputs for our investments are not available to determine their
fair value, we must then use other inputs which may include indicative pricing for securities from the same issuer with similar
terms, yield curve information, benchmark data, prepayment speeds and credit quality or unobservable inputs that reflect our
estimates of the assumptions market participants would use in pricing the investments based on the best information available
in the circumstances. When valuation techniques, other than those described as Level 1 are utilized, management must make
estimations and judgments in determining the fair value for its investments. The degree to which management’s estimation and
judgment is required is generally dependent upon the market pricing available for the investments, the availability of
observable inputs, the frequency of trading in the investments and the investment’s complexity. If we make different judgments
regarding unobservable inputs we could potentially reach different conclusions regarding the fair value of our investments.
After we have determined the fair value of our investments, for those that are in an unrealized loss position, we must then
determine if the investment is other-than-temporarily impaired. We review our investments quarterly for indicators of other-
than-temporary impairment. This determination requires significant judgment and if different judgments are used the
classification of the losses related to our investments could differ. In making this judgment, we employ a systematic
methodology that considers available quantitative and qualitative evidence in evaluating potential impairment of our
investments. If the carrying value of an available-for-sale investment exceeds its fair value, we evaluate, among other factors,
general market conditions, the duration and extent to which the fair value is less than carrying value our intent to retain or sell
the investment and whether it is more likely than not that we will not be required to sell the investment before the recovery of
its amortized cost basis, which may not be until maturity. We also consider specific adverse conditions related to the financial
health of and business outlook for the issuer, including industry and sector performance, rating agency actions and changes in
credit default swap levels. For our cost method investments, our quarterly review of impairment indicators encompasses the
analysis of specific criteria of the entity, such as cash position, financing needs, operational performance, management changes,
competition and turnaround potential. If any of the above impairment indicators are present, we further evaluate whether an
other-than-temporary impairment should be recorded. Once a decline in fair value is determined to be other-than-temporary, an
impairment charge is recorded and a new cost basis in the investment is established. See Notes 4 and 5 to our consolidated
financial statements and “Liquidity and Capital Resources” for more information on our investments and fair value
measurements.
Intangible Assets
We have acquired product related technology assets and other intangible assets from acquisitions and other third party
agreements. We allocate the purchase price of acquired intangible assets acquired through third party agreements based on their
estimated relative fair values. We allocate a portion of purchase price of acquired companies to the product related technology
assets and other intangible assets acquired based on their estimated fair values. We typically engage third party appraisal firms
to assist us in determining the fair values and useful lives of product related technology assets and other intangible assets
acquired. Such valuations and useful life determinations require us to make significant estimates and assumptions. These
estimates are based on historical experience and information obtained from the management of the acquired companies and are
inherently uncertain. Critical estimates in determining the fair value and useful lives of the product related technology assets
include but are not limited to future expected cash flows earned from the product related technology and discount rates applied
in determining the present value of those cash flows. Critical estimates in valuing certain other intangible assets include but are
not limited to future expected cash flows from customer contracts, customer lists, distribution agreements, patents, brand
awareness and market position, as well as discount rates.